Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 7, 2025 -- Sustainable development strategies are important for helping low- and middle-income countries to address the dual challenges of climate change and antimicrobial resistance (AMR), according to a study published online April 28 in Nature Medicine.
Weibin Li, from the School of Public Health at Sun Yat-sen University in Guangzhou, China, and colleagues analyzed the impact of socioeconomic and environmental factors on AMR using 4,502 AMR surveillance records involving 32 million tested isolates from 101 countries for 1999 to 2022. Forecast models were established based on several scenarios, considering a reduction in antimicrobial consumption, sustainable development initiatives, and different shared socioeconomic pathways under climate change.
Under different shared socioeconomic pathway scenarios, the researchers identified growing AMR disparities between high-income countries and low- and middle-income countries. Compared with baseline, by 2050, the most prominent effect was seen for sustainable development efforts, which reduced the prevalence of AMR by 5.1 percent, surpassing the effect of a reduction in antimicrobial consumption. Reducing out-of-pocket health expenses, comprehensive immunization coverage, adequate health investments, and universal access to water, sanitation, and hygiene services were key contributors (3.6, 1.2, 0.2, and 0.1 percent, respectively).
"Addressing the complex relationship between climate change, human activities, and AMR requires ongoing research, policy development, and the implementation of targeted interventions," the authors write. "A multifaceted and collaborative approach is critical to effectively managing AMR and safeguarding global public health."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-08 06:00
Read more

- First Weight-Loss Pill From Lilly, Orforglipron, Shows Promising Results
- Ultraprocessed Food Intake Contributes to All-Cause Mortality
- Hypertensive Disorders of Pregnancy Adversely Affect Preemie Neurodevelopment
- NIH Study Reveals How Inflammation Makes Touch Painful
- Cancer Death Rates Higher for Children in Neighborhoods With Persistent Poverty
- Gene Test Predicts Urinary Problems From Prostate Cancer Radiation Therapy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions